Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia
about
Apolipoprotein(a) acts as a chemorepellent to human vascular smooth muscle cells via integrin αVβ3 and RhoA/ROCK-mediated mechanismsThe low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humansVariation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) productionMortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality studyLipoprotein(a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbitsRisk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register GroupCurrent therapies for lowering lipoprotein (a)Human Genetics and the Causal Role of Lipoprotein(a) for Various DiseasesThe Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Systematic Review and Meta-Analysis.Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biologyElevated apolipoprotein B-48 and remnant-like particle-cholesterol in heterozygous familial hypercholesterolaemia.Prevalence of microalbuminuria, lipoprotein (a) and coronary artery disease in the lipid clinicLevels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial.Lipids, cardiovascular disease and atherosclerosis in systemic lupus erythematosus.Familial hypercholesterolemia: developments in diagnosis and treatmentLipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy.Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level.Evaluation of the effect of andrographolide on atherosclerotic rabbits induced by Porphyromonas gingivalisThe inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rateRelationship between apolipoprotein(a) phenotype, lipoprotein(a) concentration in plasma, and low density lipoprotein receptor function in a large kindred with familial hypercholesterolemia due to the pro664----leu mutation in the LDL receptor gene.Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials.Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension.Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia.Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events.Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinomaApolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrationsLipoprotein(a): an elusive cardiovascular risk factorLipoprotein (a): a Unique Independent Risk Factor for Coronary Artery Disease.Serum Lp(a) lipoprotein concentration and outcome of thrombolytic treatment for myocardial infarction.Serum lipoprotein(a) concentrations are related to coronary disease progression without new myocardial infarction.Laboratory facilities for investigating lipid disorders in the United Kingdom: results of the British Hyperlipidaemia Association survey.Limited discriminant value of lipoprotein AI, lipoprotein Lp(a) and other lipoprotein particles in patients with and without early onset ischaemic heart diseaseHomocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism.Sib-pair analysis detects elevated Lp(a) levels and large variation of Lp(a) concentration in subjects with familial defective ApoBOutcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia.Relationship between Lipoprotein(a) and Thyroid Hormones in Hypothyroid Patients.Lipoprotein(a) and incident type-2 diabetes: results from the prospective Bruneck study and a meta-analysis of published literature.Lipoprotein(a): resurrected by genetics.Fatty acids in some common food items in Canada.
P2860
Q24294266-915D6087-A187-42B7-BAC3-22C83739CE72Q24562140-580E38F0-C0F2-42DC-A537-DDCC11238028Q24601964-4193B8CC-244C-41E2-B282-5B8D07A8A0BCQ24630340-D4B72A6A-F440-415B-BB9C-EB0C883E2529Q24669902-AEF13025-65D5-43E1-9A5C-31E0DC65D595Q24675141-773A92E4-BAC2-48AA-BC17-891B5EC7E1E9Q26830297-41743314-20A8-4E83-B1F9-D8A6DC14C83BQ28079294-43216B37-57AA-4856-B94E-022F6E6B0806Q30234123-6768191E-5616-425E-85F3-71CAF2F13A52Q30242031-D08E59F9-3844-458C-AB8D-327CD9142687Q31898299-FD8D1F62-6EA1-4B78-9C8B-9266EB5A3989Q33608889-E761E8D0-9080-4D29-AABD-83ED92BBFF36Q33835341-80A4E960-9855-40F7-93E2-3C89A0448D88Q33915449-C7958629-3BAB-4ABD-9C70-84596E1B48EFQ34106665-627A5C6C-79F6-46B3-BE6E-EAAEBECE65A0Q34116379-31AB2DAE-6CC3-4EBA-93A5-4D4293CF9AB5Q34118495-E2F9BDD0-2AB0-4D7B-A510-FFC400F55A9CQ34120640-1FCD7A94-3F29-472F-9CAA-C5A8C3AF9456Q34154477-B0F655E0-1C2A-4ECC-A64F-F506E351C4EDQ34192661-05668B69-B662-4268-B1A7-5DF91A2C3D45Q35130714-7AAD60C2-70D5-4130-9727-B6973DE5C0F2Q35132715-B587E37A-FE8A-4B9C-BEA7-9CE48BC15552Q35171679-A7D34A24-0DA6-4EED-932C-A8F17C48249AQ35583268-C4240AE5-AE38-43FB-AE1C-74B1EF9ACE5CQ35592510-CD7A91CA-B457-421E-B93E-6C7FC5B89546Q35600471-030EF9AD-82E9-49A3-8FA9-7FE9381E7940Q35603379-459DE15D-CBFF-45B7-A953-DF0EADFDE8AAQ35746190-2BB22FA0-AEB8-452B-AAD7-6D5FA0361905Q36515765-C3D3A9FA-AAB0-41E0-ADFD-4126ACAE9E0DQ36812940-83ECE38F-27C3-4008-B4EC-A51252001380Q36824175-BB672ADE-7A8C-473B-AF73-EB826E55F506Q37115922-0E3B7081-762C-4B3A-B81F-E478D833199DQ37255322-4E4BB1F5-B60F-4CA1-A766-0A5E535DB46BQ37271062-591D7743-9DCD-41D7-A88C-D3CF262115DFQ37366904-C96A9EEE-5D07-4802-A344-222C69194BE8Q37370285-496BC0D0-E69A-4BFB-AA4D-5C16981D7791Q37679079-CFB695C9-56B4-45FC-9FE4-DD96EA3DBAD6Q37713534-D51022AF-BC02-46EC-B3A5-8E2FA8C72AD8Q38045424-4FC06778-0A6D-4975-BF96-687AF6A2F50EQ38567442-CC22A092-815E-423A-AA34-879EF4D366C7
P2860
Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia
description
1990 nî lūn-bûn
@nan
1990 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Relation of serum lipoprotein( ...... familial hypercholesterolemia
@ast
Relation of serum lipoprotein( ...... familial hypercholesterolemia
@en
Relation of serum lipoprotein( ...... familial hypercholesterolemia
@nl
type
label
Relation of serum lipoprotein( ...... familial hypercholesterolemia
@ast
Relation of serum lipoprotein( ...... familial hypercholesterolemia
@en
Relation of serum lipoprotein( ...... familial hypercholesterolemia
@nl
prefLabel
Relation of serum lipoprotein( ...... familial hypercholesterolemia
@ast
Relation of serum lipoprotein( ...... familial hypercholesterolemia
@en
Relation of serum lipoprotein( ...... familial hypercholesterolemia
@nl
P2093
P921
P1476
Relation of serum lipoprotein( ...... familial hypercholesterolemia
@en
P2093
D Reaveley
E Boerwinkle
F Hoppichler
G R Thompson
G Utermann
S McCarthy
P304
P356
10.1056/NEJM199005243222104
P407
P577
1990-05-24T00:00:00Z